RPA Mixture Particle Detection via Crowding Agents
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current isothermal nucleic acid amplification methods, such as Recombinase Polymerase Amplification (RPA), face challenges in efficient detection and monitoring of amplification processes, particularly in point-of-care and field settings where complex instrumentation is not feasible.
Innovation Solution
The method involves a mixture containing recombinase, single-stranded DNA binding protein, and nucleic acids, with the inclusion of crowding agents like polyethylene glycol, which allows for the formation of detectable particles associated with nucleic acid amplification, enabling rapid detection using microscopy, flow cytometry, or microfluidic devices.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If complex instrumentation is used for detection, then measurement precision is improved, but device complexity increases
Solution Approach 1:
The patent extracts the detection function from complex instrumentation to simple visual observation. By formulating particles with inherent optical properties (fluorescence, color, scattering) that can be detected by the naked eye or simple microscopes, the system removes the need for complex detection instruments while maintaining detection capability.
Solution Approach 2:
The patent creates visual copies of amplification activity through optically detectable particles. Each particle serves as a visual representation of nucleic acid amplification, allowing detection through simple optical means rather than complex instrumentation. The particles copy the signal of amplification in a visually accessible form.
2Productivity
If rapid detection is achieved, then productivity is improved, but measurement precision may worsen
Solution Approach 1:
The patent performs preliminary action by pre-formulating particles containing all necessary components (nucleic acids, proteins, crowding agents) before the amplification reaction begins. These pre-assembled particles are ready to immediately generate optical signals upon amplification, enabling rapid detection without requiring complex real-time analysis instrumentation.
Solution Approach 2:
The patent utilizes color changes and optical property changes as direct indicators of amplification. The particles exhibit visible optical changes (fluorescence, color, scattering) that can be detected rapidly and accurately, providing both speed and precision through simple optical observation rather than complex measurement.
3Ease of operation
If point-of-care applications are enabled, then ease of operation is improved, but measurement precision may worsen
Solution Approach 1:
The patent enables self-service detection where the assay system itself provides the detection signal without requiring external complex instrumentation. The particles autonomously generate optical signals through the amplification reaction, allowing users to perform and read results without specialized equipment or training, while maintaining precision through the inherent optical properties of the particles.
4Productivity
If crowding agents are added to enhance particle formation, then productivity is improved, but device complexity increases
Solution Approach 1:
The patent applies parameter changes by incorporating crowding agents that modify the physical-chemical environment to favor particle formation and amplification efficiency. The crowding agents change the solution parameters (viscosity, excluded volume) to enhance the formation of optically detectable particles, improving productivity without requiring complex device modifications.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables rapid and efficient detection of nucleic acid amplification products within minutes, facilitating point-of-care and field applications by avoiding the need for complex instrumentation and providing accurate quantitation of template nucleic acids.
Implementation Method 1
The isothermal nature and broad temperature range of the technologies can allow users to avoid the use of complex power-demanding instrumentation
Implementation Method 2
at least one of the one or more nucleic acids (e.g., oligonucleotides) includes a detectable label
Data Source
Figure 1A~1C
Figure 2A~2C
Figure 3A~3H
AI summary
A process includes providing a mixture that includes a recombinase, a single-strand binding protein, and one or more oligonucleotides; and detecting particles in the reaction mixture.